1. Graham MM. A swallowable radio transmitting radiation detector. Master's Thesis, Electrical Engineering, University of California, Berkeley, December 1966.

2. Graham R, Graham M, Graham J. Sedimentation rates for vaginal cells. Ob and Gyn 31:354-359, March 1968.

3. Graham MM. A semiautomatic blood sampler for the rat. Armed Forces Radiobiology Research Institute Technical Note TN70-4, October 1970; also published in J Appl Phys 30:772-773, 1971.

4. Graham MM. The measurement of capillary permeability changes in the irradiated rat using a double isotope technique. Armed Forces Radiobiology Research Institute Scientific Report SR 71-12, September 1971.

5. Graham MM. Capillary permeability and lymph flow in the irradiated rat. Ph.D. Thesis, Biophysics, June 1974; also published as Lawrence Berkeley Laboratory Report LBL 2499 with EL Dobson, second author.

6. Graham MM, Creekmore SP, Jahn GE, McIlroy MB. New pulsed range-gated doppler blood velocity meter. 1975 Ultrasonics Symposium Proceedings 75 CHO 994-4SU, 25-28, 1975.

7. Graham RM, Graham MM. Letter: immunosuppressive peptide in patients with cancer. N Engl J Med 292(13):701, 1975.

8. Graham RM, Graham MM. A prescreening device for cancer of the uterus. J National Cancer Institute 56:1109-1112, 1976.

9. Graham MM, Cavailloles F, Ritchie JL, Williams DL, Hamilton GW. Performance characteristics of a commercial ECG gate. J Nucl Med 21:387-390, 1980.

10. Lewellen TK, Graham MM. A low contrast phantom for daily quality control. J Nucl Med 22:279-282, 1981.

11. Epstein JB, Hatcher DC, Graham MM. Bone scintigraphy of fibro-osseous lesions of the jaw. Oral Surg 51:346-350, 1981.

12. Larson SM, Weiden PL, Grunbaum Z, Rasey JS, Kaplan HG, Graham MM, Sale GD, Harp GD, Williams DL. Positron imaging feasibility studies. I Characteristics of 3H-thymidine uptake in rodent and canine neoplasms. J Nucl Med 22:869-874, 1981.

13. Larson SM, Weiden PL, Grunbaum Z, Rasey JS, Kaplan HG, Graham MM, Sale GD, Harp GD, Williams DL. Positron imaging feasibility studies. II Characteristics of 2-deoxyglucose uptake in rodent and canine tumors. J Nucl Med 22:875-879, 1981.

14. Graham MM. Unusual ECG artifact. J Nucl Med 22(7):660, 1981.

15. Modell HI, Graham MM. Limitations of Kr-8lm for quantitation of ventilation scans. J Nucl Med 23:301-305, 1982.

16. Creekmore SP, Graham MM, Jahn GE, Targett RC, McIlroy MB. Comparison of methods of recording and analysis of Doppler blood velocity signals in normal subjects. Ultrasound in Med and Biol 8:525-535, 1982.

17. Walsh CT, Graham MM. Nursing implications in cardiovascular nuclear medicine. Cardiovascular Nursing 19:1-9, 1983.

18. Graham MM, Caputo GR. Measurement of left ventricular volume using emission computed tomography. Emission computed tomography - current trends, P.D. Esser, Ed. Society of Nuclear Medicine, NY, pages 147-154, 1983.

19. Drane WE, Graham MM, Nelp WB. Imaging of an adrenal cortical carcinoma and its skeletal metastasis. J Nucl Med 24:710-712, 1983.

20. Larson SM, Carrasquillo JA, Krohn KA, Brown JP, McGuffin RW, Ferens JM, Graham MM, Hill LD, Beaumier PL, Hellstrom KE, et al. Localization of 131L-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 72(6):2101-2114, 1983.

21. Graham MM, Abbott GL. High speed, bubble segmented blood sampler for the rat. J Appl Physiol 57: 1284-1287, 1984.

22. Shields AF, Larson SM, Grunbaum Z, Graham MM. Short-term thymidine uptake in normal and neoplastic tissues: studies for PET. J Nucl Med 25:759- 764, 1984.

23. Chesnut CH, Hanson JA, Kilcoyne RF, Murano R, Lewellen TK, Nelp WB, Mack L, Graham MM, Ott SM. Assessment of bone mass at differing skeletal sites by multiple diagnostic parameters. First International Conference on Osteoporosis - Social and Clinical Aspects, 1984. Excerpta Medica, Amsterdam.

24. Graham MM. Model simplification: Complexity vs Reduction. Circulation 72: IV-63 - IV-68, 1985.

25. Caputo GR, Graham MM, Brust KD, Kennedy JW, Nelp WB. Measurement of left ventricular volume using single-photon emission computed tomography. Am J Cardiol 56:781-786, 1985.

26. Folks F, Banks L, Plankey M, Mattera JA, Greene RA, Brust KD, Graham MM, Caputo GR. Cardiovascular SPECT. J Nucl Med Tech 13:150-161, 1985.

27. Smith JP, Graham MM. Schilling evaluation of pernicious anemia. J Nucl Med 26(9):1099-1100, 1985.

28. Baskin DG, Brewitt B, Davidson DA, Corp E, Paquette T, Figlewicz DP, Lewellen TK, Graham MM, Woods SG, Dorsa DM. Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain. Diabetes 35:246-249, 1986.

29. Lewellen TK, Graham MM, Spence AM. Quantitative autoradiography using a personal computer. J Nucl Med 27:549-554, 1986.

30. Baskin DG, Davidson D, Corp ES, Lewellen TK, Graham MM. An inexpensive microcomputer digital imaging system for densitometry: Quantitative autoradiography of insulin receptors with I-125 and LKB ultrafilm. J Neurosci Meth 16:119-129, 1986.

31. Evans ML, Graham MM, Mahler PA, Rasey JS. Changes in vascular permeability following thorax irradiation in the rat. Radiation Research 107:262-271, 1986.

32. Graham MM, Spence AM, Abbott GL, O'Gorman L, Muzi M. Blood flow in an experimental rat brain tumor by tissue equilibration and indicator fractionation. J Neuro Oncol 5:37-46, 1987.

33. Spence AM, Graham MM, O'Gorman LA, Muzi M, Abbott GL, Lewellen TK. Regional blood-to-tissue transport in an irradiated rat glioma. Rad Res 111:225-236, 1987.

34. Evans ML, Graham MM, Mahler PA, Rasey, JS. Use of steroids to suppress vascular response to radiation. Int J Rad Onc Biol Phys 13:563-567, 1987.

35. Graham MM. Detecting perfusion defects with nuclear medicine. Diag Imag 9:7:102-106, 1987.

36. Breitz HB, Sirotta PS, Graham MM. Cardiac calcification causing arrhythmia detected by Technetium-99m MDP and SPECT. Clin Nuc Med 3:153-154, 1988.

37. Modell HI, Graham MM. Use of a computer simulation to reinforce wet labs in nuclear medicine. Computers in Life Sci Ed 5:57-60, 1988.

38. Graham MM, Links JM, Lewellen TK, King MA, Croft BY, Wong DF, Esser PD, Goris ML. Considerations in the purchase of a nuclear medicine computer system. J Nucl Med 29:717-724, 1988.

39. Spence AM, Graham MM, Abbott GL, Muzi M, Lewellen TK. Blood flow changes following 137Cs irradiation in a rat glioma model. Rad Res 115:586-594, 1988.

40. Schwartz AN, Graham MM, Ferency GF, Miura RS. Radioisotope penile plethysmography: A technique for evaluating corpora cavernosal blood flow during early tumescence. J Nucl Med 30:466-473, 1989.

41. Graham MM, Spence AM, Muzi M, Abbott GL. Deoxyglucose kinetics in a rat brain tumor. J Cereb Blood Flow and Metab 9:315-322, 1989.

42. Graham MM, Lewellen TK. Editorial: Positron emission tomography and its role in metabolic imaging. Mayo Clin Proc 64:725-727, 1989.

43. Kapoor R, Spence AM, Muzi M, Graham MM, Krohn KA. Determination of the deoxyglucose and glucose phosphorylation ratio and the lumped constant in rat brain and a transplantable rat glioma. J Neurochem 53:37-44, 1989.

44. Martin RW, Graham MM, Kao R, Bashein G. Measurement of left ventricular ejection fraction and volumes with three-dimensional ultra sound scans: Comparison to radionuclide and thermal dilution measurements. J Cardiothor Anes 3:260-268, 1989.

45. Spence AM, Graham MM, Muzi M, Abbott GL, Krohn KA, Kapoor R, Woods S. Deoxyglucose lumped constant estimated in a transplanted rat astrocytic glioma by the hexose utilization index. J Cereb Blood Flow & Metab 10:190-198, 1990.

46. Graham MM, Evans ML, Dahlen DD, Mahler PA, Rasey JS. Pharmacological alteration of the lung vascular response to radiation. Int J Radiat Oncol Biol Phys 19:329-339, 1990.

47. Tsang JY, Graham MM, Robertson HT. The effects of norepinephrine on gas exchange and regional blood flows after massive bead embolization. J Critical Care 5:180-185, 1990.

48. Breitz HB, Modell HI, Graham MM. Localization of inflamation with 111In IgG and 99mTc albumin colloid labelled leukocytes in a rabbit model. Nucl Med Comm 11:737-745, 1990.

49. Lakshminarayan S, Kowalski TF, Kirk W, Graham MM, Butler J. The drainage routes of the bronchial blood flow in anesthetized dogs. Resp Physiol 82:65-74, 1990.

50. Nessly ML, Bashein G, Detmer PR, Graham MM, Kao R, Martin RW. Left ventricular ejection fraction: Single-plane and multiplanar transesophageal echocardiography versus equilibrium gated-pool scintigraphy. J Cardiothor Vasc Anes 5:40-45, 1991.

51. Schwartz AN, Graham MM. Combined Technetium radioisotope penile plethysmography and Xenon washout: A technique for evaluating corpora carevnosal inflow and outflow during tumescence. J Nucl Med 32:404-410, 1991.

52. Steen RG, Graham MM. 31P magnetic resonance spectroscopy is sensitive to tumor hypoxia: Perfusion and oxygenation of rat 9L gliosarcoma after treatment with BCNU. NMR in Biomed 4:117-124, 1991.

53. Staker BL, Graham MM. Effect of bicarbonate on stability of the Gallium-Transferrin complex. J Nucl Med 32:1439-1441, 1991.

54. Graham MM, Evans ML. A simple, dual tracer method for the measurement of transvascular flux of albumin into the lung. Micro Vasc Res 42:266-279, 1991.

55. Lewis DH, Graham MM. Benefit of tomography in the scintigraphic localization of cerebrospinal fluid leak. J Nucl Med 32(11):149-151, 1991.

56. Larson AM, Graham MM. Demonstration of pleural cerebrospinal fluid leak by In-111 DTPA radionuclide myelogram. Clin Nucl Med 17:754-5, 1992.

57. Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, Krohn KA, Griffin TW. Imaging of hypoxia in human tumors with [F-18] fluoro-misonidazole. Int J Radiat Oncol Biol Phys 22:199-212, 1992.

58. Peterson LM, Evans ML, Graham MM, Eary JF, Dahlen DD. Vascular response to radiation injury in the lung. Rad Res 129:139-148, 1992.

59. Shields AF, Graham MM, Kozawa SM, Kozell LB, Link JM, Swenson ER, Spence AM, Bassingthwaighte JB, Krohn KA. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. J Nucl Med 33:581-4, 1992

60. Kenney J, Schmiedl U, Maravilla K, Starr F, Graham MM, Spence A, Nelson J. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with Gadolinium-DTPA. Mag Res in Med 27:68-75, 1992.

61. Martin GV, Caldwell JH, Graham MM, Grierson JR, Kroll K, Cowan MJ, Lewellen TK, Rasey JS, Casciari JJ, Krohn KA. Noninvasive detection of hypoxic myocardium using Fluorine-18-fluoromisonidazole and positron emission tomography. J Nucl Med 33:2202-2208, 1992.

62. Roy-Byrne P, Fleishaker J, Arnett C, Dubach M, Stewart J, Radant A, Veith R, Graham M. Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation, and plasma catecholamines. Neuropsychopharm 8:161-169, 1993.

63. Graham MM, Lewellen BL. High-speed automated discrete blood sampling for positron emission tomography. J Nucl Med 34:1357-1360, 1993.

64. Lewis DH, Jacobson AF, Graham MM. Renin-dependent renal parenchymatous hypertension detected by angiotensin-converting enzyme inhibitor renography. Am J Nephrol 13:281-285, 1993.

65. Steen RG, Kromhout-Schiro S, Graham MM. Relationship of perfusion to edema in the 9L gliosarcoma. J Neuro Oncol 16: 81-87, 1993.

66. Bassingthwaighte JB, Revenaugh JR, Deussen A, Graham MM, Lewellen TK, Link JM, Krohn KA. Evaluation of coronary perfusion by positron emission tomography. In: Recent Advances in Coronary Circulation, edited by Maruyama Y, Kajiya F, Hoffman JIE, Spaan JAE. Tokyo: Springer-Verlag, 1993, p. 2-16.

67. Lamm WJ, Graham MM, Albert RK. Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 150: 184-193, 1994.

68. Swenson ER, Graham MM, Hlastala MP. Acetazolamide slows Va/Q matching after changes in regional blood flow. J Appl Physiol 78:1312-1318, 1995.

69. Shields AF, Graham MM, Spence AM. The role of PET imaging in clinical oncology: A current status report. Nuc Med Annual 129-168, 1995.

70. Koh WJ, Bergman KS, Rasey JS, Peterson LM, Evans ML, Graham MM, Grierson JR, Lindsley KL, Lewellen TK, Krohn KA, Griffin TW. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Rad Oncol Biol Phys 33:391-398, 1995.

71. Singh NP, Graham MM, Singh V, Kahn A. Induction of DNA single strand breaks in human lymphocytes by low doses of x-rays. Int J Radiat Biol 68:563-569, 1995.

72. Casciari JJ, Graham MM, Rasey JS. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. Med Phys 22:1127-1139, 1995.

73. Parker JA, Wallis JW, Halama JR, Brown CV, Cradduck TD, Graham MM, Wu E, Wagenaar DJ,Mammone GL, Greenes RA, Holman BL. Collaboration using Internet for the development of case-based teaching files: Report of the computer and instrumentation council internet focus group. J Nucl Med 37:178-184, 1996.

74. Shields AF, Mankoff D, Graham MM, Zheng M, Kozawa SM, Link JM, Krohn KA. Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging. J Nucl Med 37:290-296, 1996.

75. Rasey JS, Koh WJ, Evans ML, Peterson LM, Lewellen TK, Graham MM, Krohn KA. Quantifying regional hypoxia in human tumors with positron emission tomography of [F18] fluoromisonidazole: A pretherapy study of 37 patients. Int J Rad Oncol Phys 36:417-428, 1996.

76. Mankoff DA, Shields AF, Graham MM, Link JM, Krohn KA. A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites. J Nucl Med 37(123):2049-2057, 1996.

77. Sweet IR, Peterson L, Kroll K, Goodner CJ, Berry M, Graham MM. Effect of glucose on uptake of radiolabeled glucose, 2-DG, and 3-O-MG by the perfused rat liver. Am J Physiol 271(2 Pt 1):E384-396, 1996.

78. Spence AM, Graham MM, Muzi M, Freeman SD, Link JM, Grierson JR, O'Sullivan F, Stein D, Abbott GL, Krohn KA. Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: Studies in rat brain tumor models. J Nucl Med 38:617-624, 1997.

79. Graham MM. Physiologic smoothing of blood time-activity curves for PET data analysis. J Nucl Med 38:1161-1168 1997.

80. Graham MM, Peterson LM, Link JM, Evans ML, Rasey JS, Koh WJ, Caldwell JH, Krohn KA. Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies. J Nucl Med 38:1631-1635, 1997.

81. Spence AM, Muzi M, Graham MM, O'Sullivan F, Krohn KA, Link JM, Lewellen TK, Lewellen B, Freeman SD, Berger MS, Ojemann GA. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[11C]glucose and FDG: Analysis of the FDG lumped constant. J Nucl Med 39:440-448, 1998.

82. Graham MM, Peterson LM, Muzi M, Graham BB, Spence AM, Link JM, Krohn KA. 1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies. J Nucl Med 39:1805-1810, 1998.

83. Shields AF, Mankoff DA, Link JM, Graham MM, Eary JF, Kozawa SM, Zheng M, Lewellen B, Lewellen TK, Grierson JR, Krohn KA. Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med 39:1757-1762, 1998.

84. Eubank WB, Mankoff DA, Schmiedl UP, Winter TC 3rd, Fisher ER, Olshen AB, Graham MM, Eary JF. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. Am J Roentgenol 171:1103-1110, 1998.

85. Mankoff DA, Shields AF, Graham MM, Link JM, Eary JF, Krohn KA. Kinetic analysis of 2-[carbon-11] thymidine PET imaging studies: compartmental model and mathematical analysis. J Nucl Med 39:1043-1055, 1998.

86. Rajendran JG, Graham MM. In-111-labeled leukocyte infection imaging: false-positive results caused by wound dressing and hematoma. Clin Nucl Med 24:126-127, 1999.

87. Mankoff DA, Shields AF, Link JM, Graham MM, Muzi M, Peterson LM, Eary JF, Krohn KA. Kinetic analysis of 2-[11C] thymidine PET imaging studies: validation studies. J Nucl Med 40(4):614-624, 1999.

88. Graham MM, Peterson LM, Hayward RM. Comparison of simplified quantitative analysis of FDG uptake. Nucl Med Biol 27(7):647-655, 2000.

89. Rasey JS, Casciari JJ, Hofstrand PD, Muzi M, Graham MM, Chin LK. Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole. Radiation Research 153: 84-92, 2000.

90. Blankenberg FG, Eckelman WC, Strauss W, Welch MJ, Alavi A, Anderson C, Bacharach S, Blasberg RG, Graham MM, Weber W. Role of radionuclide imaging in trials of antiangiogenic therapy. Academic Radiology 7(10:851-867, 2000.

91. Graham MM. Combined 18 F-FDG-FDOPA Tumor Imaging for Assessing Response to Therapy. J Nuc Med 42(2):257-258, 2001.

92. Rideout DJ, Graham MM. Buttock Granulomas: A Consequence of Intramuscular Injection of Sandostatin Detected by In-111 Octreoscan. Clin Nucl Med 26(7):650, 2001.

93. Lewis DH, Mayberg HS, Fischer ME, Goldberg J, Ashton S, Graham MM, Buchwald D. Monozygotic twins discordant for chronic fatigue syndrome: Regional cerebral blood flow SPECT. Radiology 219:766-773, 2001.

94. Mankoff DA, Peterson LM, Tewson TJ, Link JM, Gralow JR, Graham MM, Krohn KA. [18F] fluoroestradiol radiation dosimetry in human PET studies. J Nucl Med 42(4):679-684, 2001.

95. Muzi M, Freeman SD, Burrows RC, Wiseman RW, Link JM, Krohn KA, Graham MM, Spence AM. Kinetic characterization of hexokinase isoenzymes from gliomas cells: implications for FDG imaging of human brain tumors. Nucl Med Biol 28(2):107-116, 2001.

96. Reddy MP, Menda Y, Floresca J, Juweid M, Graham MM. FDG PET imaging of pseudo-pseudo tumor. Clinical Nuclear Medicine, 27(6):445-446, 2002.

97. Reddy MP, Floresca J, Juweid M, Graham MM. Unusual bilaterally symmetrical osteolytic metastases visualized on bone scintigraphy. Clinical Nuclear Medicine, 27(4):299-301, 2002.

98. Ponto JA, Graham MM, Bricker JA. Alternatives to Technetium 99m Pentetate for radioaerosol inhalation lung imaging. J Amer Pharm Assoc 42(1):112-114, 2002.

99. Kernstine K, McLaughlin K, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, Graham MM, Brown CK, Madsen MT. Can FDG PET reduce the need for mediastinoscopy in potentially respectable non-small cell lung cancer (NSCLC)? Annals Thorac Surg 73(2):394-401; discussion 401-402, 2002.

100. Spence AM, Muzi M, Graham MM, O'Sullivan F, Link JM, Lewellen TK, Lewellen B, Freeman SD, Mankoff DA, Eary JF, Krohn KA. 2-[18F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome. Clin Cancer Res 8:971-979, 2002.

101. Juweid ME, Menda Y, O'Dorisio MS, Bushnell D, Blake M, Madsen M, Johnson J, Graham M. 111In-Pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma. Nucl Med Commun 23:2002.

102. Graham MM. Is quantitation necessary for oncological PET studies? For. Eur J Nucl Med Mol Imaging 29(1):135-138, 2002.

103. Graham MM, Muzi M, O'Sullivan F, Lewellen TK, Link JM, Krohn KA. The fluorodeoxyglucose lumped constant in normal human brain. J Nucl Med 43:1157-1166, 2002.

104. Ponto LLB, Graham MM, Richmond JC, Ward CA, Clermont DA, Schmitt BA, Clark J, Conklin A, Weldon L, Watkins GL, Madsen MT, Hichwa RD. Contamination levels in blood samples drawn from the injection intravenous line. Molec Imag Biol 4(6):410-414, 2003.

105. Reddy MP, Graham MM. FDG positron emission tomographic imaging of thoracic Castleman's disease. Clin Nucl Med. 2003 Apr;28(4):325-6.

106. Alavi A, Blahd WH, DeNardo SJ, Graham MM, Holder LE, Larson SM, Maurer AH, Miller TR, Nusynowitz ML, Palestro CJ, Parker JA, Schelbert HR, Taylor AT Jr, Treves ST. Components of professional competence for nuclear medicine physicians. J Nucl Med. 2003 Jun;44(6):988-90.

107. Cooper CS, Madsen MT, Austin JC, Hawtrey CE, Gerard LL, Graham MM. Bladder pressure at the onset of vesicoureteral reflux determined by nuclear cystometrogram. J Urol. 2003 Oct;170(4 Pt 2):1537-40; discussion 1540.

108. Buatti J, Yao M, Dornfeld K, Skwarchuk M, Hoffman HT, Funk GF, Smith RB, Graham SM, Menda Y, Graham MM. Efficacy of IMRT in head and neck cancer as monitored by post-RT PET scans. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl):S305.

109. Yao M, Buatti J, Dornfeld KJ, Skwarchuk M, Menda Y, Graham MM, Smith RB, Graham SM, Funk GF, Hoffman HT. Is neck dissection necessary when post-radiation PET is negative after radiation treatment for locally advanced head and neck cancer? Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl):S244-5.